Supplier
Healtheast Medical Research Institute
Healtheast Medical Research Institute was paid $7.44M by Medicaid between Jan 2018 and Dec 2024, across 117 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 27% of everything it billed.
33Billing provider infoHEALTHEAST MEDICAL RESEARCH INSTITUTE
MAPLEWOOD, MN 55109
MAPLEWOOD, MN 55109
33aNPI1689616716assigned 06/12/2006
33bProvider typeDurable Medical Equipment & Medical Supplies
28Total paid$7.44M
24GClaims223,589
24DCodes billed117
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Durable Medical Equipment & Medical Supplies providers in Minnesota
Rank by total paid#24 of 319
Median peer was paid$23K
This provider vs. median321×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official RING, MAUREEN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 28,486 | $299K | |
| 2019 | 37,032 | $1.22M | |
| 2020 | 27,834 | $1.02M | |
| 2021 | 41,202 | $1.64M | |
| 2022 | 38,028 | $1.46M | |
| 2023 | 27,308 | $983K | |
| 2024incomplete | 23,699 | $820K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 27% | 39,055 | 35,954 | $1.99M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 22% | 24,684 | 22,618 | $1.63M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 9.5% | 9,322 | 8,932 | $705K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 7.0% | 11,933 | 11,542 | $520K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 5.5% | 6,446 | 6,214 | $406K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.3% | 4,239 | 3,968 | $243K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.0% | 3,156 | 3,095 | $224K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 2.5% | 7,852 | 7,512 | $186K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.2% | 1,654 | 1,555 | $160K |
| X5622 | 2.1% | 3,718 | 3,599 | $157K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.5% | 8,564 | 8,305 | $115K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.5% | 1,201 | 1,158 | $112K |
105 more codes
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.3% | 3,344 | $98K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.3% | 2,852 | $95K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.3% | 5,585 | $94K |
| 36415 | Collection of venous blood by venipuncture | 1.0% | 22,080 | $77K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 3,530 | $66K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 797 | $58K |
| 99188 | <1% | 5,720 | $53K | |
| 90461 | <1% | 1,421 | $29K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 520 | $24K |
| 92551 | <1% | 3,200 | $21K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 3,379 | $20K |
| 80053 | Comprehensive metabolic panel | <1% | 2,032 | $20K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,227 | $19K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 688 | $18K |
| 85027 | <1% | 3,169 | $18K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,180 | $17K |
| 80061 | Lipid panel | <1% | 1,290 | $16K |
| 90686 | <1% | 5,332 | $16K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,288 | $16K |
| 87650 | <1% | 945 | $15K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,184 | $14K |
| 99243 | <1% | 149 | $12K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 309 | $12K |
| 90480 | <1% | 535 | $12K | |
| 96127 | <1% | 2,560 | $10K | |
| 92567 | <1% | 1,125 | $9K | |
| 99000 | <1% | 669 | $8K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 231 | $8K |
| 92557 | <1% | 375 | $8K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 214 | $7K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 76 | $6K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 217 | $5K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 113 | $5K |
| 81001 | <1% | 1,614 | $5K | |
| 99173 | <1% | 3,463 | $5K | |
| 90670 | <1% | 2,244 | $4K | |
| 87186 | <1% | 523 | $4K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 532 | $4K |
| 99442 | <1% | 144 | $4K | |
| 91320 | <1% | 44 | $4K | |
| 83970 | <1% | 106 | $4K | |
| 81025 | <1% | 465 | $4K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 437 | $3K |
| 82728 | <1% | 237 | $3K | |
| 82607 | <1% | 225 | $3K | |
| 87210 | <1% | 564 | $3K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 101 | $2K |
| 85018 | <1% | 1,112 | $2K | |
| 0071A | <1% | 61 | $2K | |
| 96161 | <1% | 1,115 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 204 | $2K |
| 0072A | <1% | 47 | $2K | |
| 90715 | <1% | 106 | $2K | |
| 99421 | <1% | 157 | $2K | |
| 86803 | <1% | 112 | $2K | |
| 86780 | <1% | 89 | $1K | |
| 82565 | <1% | 349 | $1K | |
| 0054A | <1% | 29 | $1K | |
| 90656 | <1% | 605 | $1K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 446 | $1K |
| 0124A | <1% | 32 | $1K | |
| 84460 | <1% | 218 | $978.41 | |
| 87807 | <1% | 58 | $787.72 | |
| 90474 | <1% | 86 | $774.97 | |
| 92587 | <1% | 64 | $732.12 | |
| 99460 | <1% | 17 | $691.90 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 71 | $606.83 |
| 90662 | <1% | 13 | $604.02 | |
| 83655 | <1% | 51 | $590.64 | |
| 36416 | <1% | 186 | $473.11 | |
| 86140 | <1% | 83 | $405.76 | |
| 92550 | <1% | 34 | $386.04 | |
| 90677 | <1% | 320 | $318.56 | |
| 90473 | <1% | 12 | $254.64 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 46 | $244.14 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 61 | $237.66 |
| 82040 | <1% | 71 | $199.85 | |
| 82746 | <1% | 13 | $198.34 | |
| 90680 | <1% | 990 | $193.48 | |
| 90723 | <1% | 1,223 | $192.50 | |
| 96381 | <1% | 17 | $180.84 | |
| T1013 | Sign language or oral interpretive services, per 15 minutes | <1% | 15 | $167.55 |
| 99441 | <1% | 27 | $161.08 | |
| 90688 | <1% | 83 | $154.24 | |
| 81003 | <1% | 151 | $135.74 | |
| 77080 | <1% | 12 | $109.26 | |
| 85652 | <1% | 35 | $87.24 | |
| 90707 | <1% | 28 | $84.90 | |
| 90648 | <1% | 1,923 | $73.45 | |
| 84550 | <1% | 12 | $55.99 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 16 | $14.50 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 42 | $2.24 |
| 90696 | 0% | 28 | $0.00 | |
| 90381 | 0% | 32 | $0.00 | |
| 90697 | 0% | 149 | $0.00 | |
| 90651 | 0% | 42 | $0.00 | |
| 91317 | 0% | 44 | $0.00 | |
| 91318 | 0% | 92 | $0.00 | |
| 90716 | 0% | 29 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 14 | $0.00 |
| 91319 | 0% | 12 | $0.00 | |
| 90685 | 0% | 273 | $0.00 | |
| 90710 | 0% | 12 | $0.00 | |
| 90734 | 0% | 53 | $0.00 | |
| 90633 | 0% | 508 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRING, MAUREEN (SYS DIR GOVT REIMB & NETWK REL)
Parent organizationHEALTHEAST MEDICAL RESEARCH INSTITUTE
| Provider | Location | Paid |
|---|---|---|
| Fairview Health Services | Minneapolis, MN | $90.41M |
| Fairview Health Services | Saint Paul, MN | $48.52M |
| Fairview Health Services | Burnsville, MN | $29.98M |
| Fairview Health Services | Minneapolis, MN | $26.56M |
| Healtheast ST. John's Hospital | Maplewood, MN | $17.91M |
| Fairview Health Services | Edina, MN | $17.24M |
| Healtheast Medical Research Institute | Saint Paul, MN | $11.37M |
| Fairview Clinics | Bloomington, MN | $9.40M |
| Fairview Health Services | Princeton, MN | $9.36M |
| Healtheast Medical Research Institute | Saint Paul, MN | $8.76M |
| Healtheast Medical Research Institute | Saint Paul, MN | $8.29M |
| Fairview Clinics | Brooklyn Park, MN | $8.06M |
| Fairview Health Services | Wyoming, MN | $7.71M |
| Healtheast Woodwinds Hospital | Woodbury, MN | $6.17M |
| Fairview Clinics | Burnsville, MN | $4.75M |
| Fairview Clinics | Minneapolis, MN | $4.75M |
| Fairview Express Care | Saint Paul, MN | $4.57M |
| Fairview Clinics | Saint Paul, MN | $4.37M |
| Healtheast Medical Research Institute | Woodbury, MN | $4.07M |
| Fairview Clinics | Princeton, MN | $4.05M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.